Clinical Research - The Aurum Institute

Aurum PI appointed Co-Chair for MATRIX study

The Aurum Institute is pleased to present Dr Kathryn Mngadi, Aurum Principal Investigator (PI) and Tembisa CRS Leader as a co-chair for the MATRIX-003 study. The MATRIX-003, sponsored by MATRIX, A US...
Scientists graduate from IAVI Leadership Programme

Three Aurum scientists have graduated from the inaugural cohort of the IAVI ADVANCE Leadership Development Programme (LDP). Aurum’s Dr William Brumskine: Rustenburg Clinical Research Site Leader, ...
World TB Month: Aurum CAB member survives TB and now helps others do the same

As an Aurum Community Advisory Board (CAB) member and a tuberculosis (TB) survivor, Wellington Radebe is fully equipped in assisting health facilities in Tembisa to end TB within communities and firml...
Is SA any closer to HIV vaccine?

...
Partnerships to improve health for mine workers

The Aurum Institute together with the North West Department of Health (NW DOH) and the mining sector officially launched the Tier.Net project at the Sibanye Stillwater mine in Rustenburg South Africa ...
Aurum Scientist honoured in the M&G 200 Young list

The Aurum Institute is proud to announce that Dr. Sandile Cele, a scientist at Aurum has been honoured as one of the candidates of the 200 Young South Africans by Mail & Guardian. This prestigiou...
HIV Vaccine Awareness Day: Paving the Way for an #HIVFreeFuture

Today, May 18, we commemorate HIV Vaccine Awareness Day (HVAD), a date that symbolizes our ongoing commitment, relentless effort, and shared passion for creating a world without HIV/AIDS. On this...
From a Rural Village to a PhD: Dr. Bonolo Pitse's Extraordinary Story of Resilience and Passion

In a world full of inspiring stories, Bonolo Pitse stands out as a remarkable example of determination, resilience, and the power of passion. Growing up in a remote rural village with financial limita...
Growing the beta variant – young scientist remembers the day they danced in the lab

...
Aurum welcomes new TB funding commitment by donors

The Aurum Institute welcomes the recent announcement by Wellcome and the Bill & Melinda Gates Foundation to advance a tuberculosis (TB) vaccine candidate, M72/AS01E (M72), through a Phase III clin...
Aurum staff embrace Ubuntu on Nelson Mandela Day

Motivated by the Nelson Mandela quote, "It is in your hands to make a better world for all who live in it," Aurum staff in the North West province joined hands to make a difference in the lives of the...
Key Takeaways from IAS 2023: Part 1

The 12th IAS Conference on HIV Science, IAS 2023, brought together delegates from The Aurum Institute and around the world to share research and remarkable achievements in the battle against HIV. This...
Pretoria North’s Health and Social Outreach Event Hosted by Metro

...
KZN’s Dr Cele reflects on the joy of his Covid-19 milestone

...
IAVI’s Human Immunology Laboratory relocates samples to Africa, fulfilling capacity strengthening goal

...
PanTB-HM Clinical Trial Begins Recruitment in South Africa

The panTB-HM clinical trial has begun patient recruitment in South Africa, with first patient dosed on 28 July 2023. This trial is a historic milestone in the quest to revolutionise tuberculosis (TB) ...
Royal Bafokeng leader visits Aurum Rustenburg CRS

The Aurum Rustenburg Clinical Research Site (CRS) welcomed His Royal Highness (HRH), Dr Koketso Rakhudu, leader of the Royal Bafokeng Nation’s community of Tsitsing, and Chief Executive Director o...
Phase 2 Clinical Trial Results Show Potential to Shorten TB Treatment Time

...
Aurum Leadership Roadshow takes Klerksdorp

Aurum Leadership is on the move once again, and this time we've joined forces with the remarkable Aurum Klerksdorp Clinical Research and Health Systems. Opening the day, Group CEO, Prof Gavin Churchy...
New drug could be a breakthrough in treatment for killer TB, trial suggests

...